Platelet function inhibitors

Citations 211-220 of 249 total displayed.

Past content (since Oct 2000):

Clinician Update
Oral Anticoagulation for Acute Coronary Syndromes: Marc A. Brouwer and Freek W.A. Verheugt
Circulation 2002;105:1270-1274, doi:10.1161/hc1102.105594 [Full text]

Clinical Investigations and Reports
Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein ${alpha}$ _IIbß₃ (GPIIb/IIIa) and ${alpha}$ _vß₃ Receptors Are Not Protected From Atherosclerosis: O. Shpilberg, I. Rabi, K. Schiller, R. Walden, D. Harats, K.S. Tyrrell, B. Coller, and U. Seligsohn
Circulation 2002;105:1044-1048; published online before print as doi:10.1161/hc0902.104676 [Abstract] [Full text]

Correspondence
Synergism Among Flavonoids in Inhibiting Platelet Aggregation and H₂O₂ Production • Response: F. Violi, P. Pignatelli, F.M. Pulcinelli, Jane E. Freedman, Crawford Parker, III, Liqing Li, Jacob A. Perlman, Balz Frei, Vadim Ivanov, Leslie R. Deak, Mark D. Iafrati, and John D. Folts
Circulation 2002;105:e53 [Full text]

Articles
Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein ${alpha}$ _IIbß₃ (GPIIb/IIIa) and ${alpha}$ _vß₃ Receptors Are Not Protected From Atherosclerosis: O. Shpilberg, I. Rabi, K. Schiller, R. Walden, D. Harats, K. S. Tyrrell, B. Coller, and U. Seligsohn
Circulation published February 11, 2002, doi:10.1161/hc0902.104676 [Abstract]

Clinical Investigations and Reports Department of Veterans Affairs Cooperative Studies Program Clinical Trial Comparing Combined Warfarin and Aspirin With Aspirin Alone in Survivors of Acute Myocardial Infarction: Primary Results of the CHAMP Study: Louis D. Fiore, Michael D. Ezekowitz, Mary T. Brophy, David Lu, Joseph Sacco, and Peter Peduzzi
Circulation 2002;105:557-563, doi:10.1161/hc0502.103329 [Abstract] [Full text]

Clinical Investigations and Reports
Randomized, Placebo-Controlled Trial of Titrated Intravenous Lamifiban for Acute Coronary Syndromes: Circulation 2002;105:316-321, doi:10.1161/hc0302.102573 [Abstract] [Full text]

Clinical Investigations and Reports Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting: Results From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial: Marino Labinaz, Rakhi Kilaru, Karen Pieper, Steven P. Marso, Michael M. Kitt, Maarten L. Simoons, Robert M. Califf, Eric J. Topol, Paul W. Armstrong, and Robert A. Harrington
Circulation 2002;105:322-327, doi:10.1161/hc0302.102578 [Abstract] [Full text]

Correspondence
Platelet Inhibition After Glycoprotein IIb/IIIa Inhibitor Therapy: Michele Galli
Circulation 2001;104:e163 [Full text]

Clinical Investigations and Reports
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes: Marco Roffi, Derek P. Chew, Debabrata Mukherjee, Deepak L. Bhatt, Jennifer A. White, Christopher Heeschen, Christian W. Hamm, David J. Moliterno, Robert M. Califf, Harvey D. White, Neal S. Kleiman, Pierre Théroux, and Eric J. Topol
Circulation 2001;104:2767-2771, doi:10.1161/hc4801.100029 [Abstract] [Full text]

Clinical Investigations and Reports
Pl^A2 Polymorphism of ß₃ Integrins Is Associated With Enhanced Thrombin Generation and Impaired Antithrombotic Action of Aspirin at the Site of Microvascular Injury: Anetta Undas, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation 2001;104:2666-2672, doi:10.1161/hc4701.099787 [Abstract] [Full text]

Subspecialty Collections Home

Show Platelet function inhibitors
collections from other journals.